8. Detection Of Cmv Infection By Biopsy In Recipients With Kidney Graft Dysfunction

Authors

  • B.B. Baimakhanov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • R.P. Ibragimov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • E.A. Enin National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • I.K. Madadov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • Zh.M. Syrymov National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • E.B. Belgibaev National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan
  • K.S. Dabyltaeva National Scientific Center of Surgery named after A.N. Syzganov, Almaty, Kazakhstan

Downloads

Abstract

Kidney transplantation is the most effective and preferable treatment option of terminal stage of chronic kidney disease. Nowadays kidney transplantation is well-developed modality and early graft and patient survival rates overall the world greatly increased. But improvement of graft and patient survival rates in long-term period remains to be problem. Beside the immunologic factors that causes either acute or chronic graft rejection, there are another etiologic factors of graft rejection. Infections, particularly wide-spread in solid organ recipients - cytomegalovirus infection (CMV), appears to be one of this etiologic factors. Mechanism of injury of graft by cytomegalovirus remains to be unclear. Diagnostics of CMV is also a difficult. objective. In our institution we conducted an investigation aimed the detection of CMV by graft biopsy in patients with graft dysfunction. The main objective of this investigation is the demonstration of efficacy of biopsy in diag-nostics of CMV infection in graft dysfunction.

Keywords

cytomegalovirus, graft dysfunction, biopsy, kidney transplantation

References

  1. Kim WR, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: Liver. Am J Transplant 2014; 14(Suppl 1): 69–96
  2. Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2012 annual data report: Kidney. Am J Transplant 2014; 14(Suppl 1): 11–44
  3. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Co-simi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580–590
  4. Fishman JA. Infection in solid-organ transplant re-cipients. N Engl J Med 2007; 357: 2601–2614
  5. Lodhi SA, Lamb KE, Meier-Kriesche HU. Solid organ allograft survival improvement in the United States: The long-term does not mirror the dramatic short-term success. Am J Transplant 2011; 11: 1226–1235
  6. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: A critical reappraisal. Am J Transplant 2011; 11: 450–462
  7. Land WG. Chronic allograft dysfunction: A model disorder of innate immunity. Biomed J 2013; 36: 209–228
  8. Razonable RR, Paya CV. Infections and allograft re-jection - intertwined complications of organ trans-plantation. Swiss Med Wkly 2005; 135: 571–573
  9. Shoskes DA. Nonimmunologic renal allograft injury and delayed graft function: Clinical strategies for prevention and treatment. Transplant Proc 2000; 32: 766–768
  10. Ho M. Cytomegalovirus infection and indirect sequel-ae in the immunocompromised transplant patient. Transplant Proc 2011;23 [Suppl 1]:2–7
  11. Hibberd PL, Tolkoff‐Rubin NE, Cosimi AB et al. Symp-tomatic cytomegalovirus disease in the cytomegalo-virus antibody seropositive renal transplant recipient treated with OKT3. Transplantation,2012;53:68–72
  12. KDIGO clinical practice guideline for the care of kid-ney transplant recipients: a summary.Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM, Kidney Disease: Improving Global Outcomes.KidneyInt. 2010 Feb; 77(4):299-311
  13. Prevention of cytomegalovirus disease in recipients of solid-organ transplants.Paya CVClin Infect Dis. 2001 Feb 15; 32(4):596-603
  14. Kotton CN, Fishman JA.Viral infection in the re-nal transplant recipients. J Am SocNephrol. 2005;16(6):1758–1774. Review
  15. Liapis H1, Storch GA, Hill DA, Rueda J, Brennan DC.CMV infection of the renal allograft is much more common than the pathology indicates: a retrospec-tive analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR.NephrolDialTransplant. 2003 Feb;18(2):397-402
  16. Boshra Hasanzamani,* Maryam Hami, Vajihe Zol-faghari, Mahtab Torkamani, Mahin Ghorban Saba-gh, and Saiideh Ahmadi Simab “The effect of cyto-megalovirus infection on acute rejection in kidney transplanted patients” J Renal Inj Prev. 2016; 5(2): 85–88

Published

2019-07-01

Issue

No. 2 (2019)

Section

Статьи